Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) vs insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial.
Wysham, Carol
Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) vs insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. [electronic resource] - Diabetes, obesity & metabolism 10 2017 - 1408-1415 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1463-1326
10.1111/dom.12961 doi
Adult
Aged
Blood Glucose--drug effects
Body Mass Index
Body Weight--drug effects
Diabetes Mellitus, Type 2--blood
Drug Combinations
Female
Glycated Hemoglobin--metabolism
Humans
Hypoglycemia--chemically induced
Insulin Glargine--administration & dosage
Male
Middle Aged
Peptides--administration & dosage
Time Factors
Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) vs insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. [electronic resource] - Diabetes, obesity & metabolism 10 2017 - 1408-1415 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1463-1326
10.1111/dom.12961 doi
Adult
Aged
Blood Glucose--drug effects
Body Mass Index
Body Weight--drug effects
Diabetes Mellitus, Type 2--blood
Drug Combinations
Female
Glycated Hemoglobin--metabolism
Humans
Hypoglycemia--chemically induced
Insulin Glargine--administration & dosage
Male
Middle Aged
Peptides--administration & dosage
Time Factors